A new Medicare program launching July 1 broadens access to drugs like Zepbound and Foundayo, but federal annuitants need to know how the $50 copay will affect their catastrophic limits.
Anchalee Phanmaha/Getty Images
Sponsor Message
Get the latest on need-to-know topics for federal employees delivered to your inbox.
Register for Newsletter
Common assumptions about Part B, IRMAA and FEHB coordination can obscure how coverage and costs actually play out over time.
News and commentary from the endocrinology world
We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare…
Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But questions…
Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.
